Diversify Wealth Management »

Bioxcel Therapeutics shares owned by Diversify Wealth Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Diversify Wealth Management from 13F filings

Historical chart of Diversify Wealth Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Diversify Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Diversify Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 40k 0.58
2024-06-30 $37k 40k 0.92

More positions owned by Diversify Wealth Management

Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Bny Mellon Etf Trust Us Mdcp Core Eqt (BKMC)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)

View all positions for Diversify Wealth Management

Top funds holding Bioxcel Therapeutics

Armistice Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Wells Fargo & Company
Renaissance Technologies
State Street Corporation
Morgan Stanley
Goldman Sachs Group
Bank of America Corporation
Citadel Advisors
Jane Street
Susquehanna International
Bnp Paribas Arbitrage, Snc

View all funds holding Bioxcel Therapeutics